resveratrol has been researched along with Hypertension in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (15.79) | 29.6817 |
| 2010's | 46 (60.53) | 24.3611 |
| 2020's | 18 (23.68) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, NB; Bostanci, A; Demirel-Yilmaz, E; Dönmez, MO; Sadi, G; Uludag, MO | 1 |
| Al-Ani, B; Dawood, AF; Ebrahim, HA; Ellatif, MA; Haidara, MA; Kamar, SS; Latif, NSA; ShamsEldeen, AM | 1 |
| An, Q; Hu, J; Hu, Y; Jin, T; Leng, B; Qin, X; Zhou, B | 1 |
| Feng, ZP; Fu, LY; Gao, HL; Jia, H; Kang, YM; Li, RJ; Li, Y; Liu, KL; Qi, J; Qiao, JA; Tan, H; Yi, QY; Yu, JY; Yu, XJ | 1 |
| Crowe-White, KM; DiNatale, JC | 1 |
| Liu, J; Wang, Y; Yao, L | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Becherescu, A; Butnariu, M; Cruz-Martins, N; Ekaterina Robertovna, G; Fratantonio, D; Herrera-Bravo, J; Iriti, M; Kumar, M; Les, F; López, V; Martorell, M; Pentea, M; Rasul Suleria, HA; Sarac, I; Setzer, WN; Sharifi-Rad, J; Sukreet, S | 1 |
| Jia, N; Shi, J; Sun, Q; Wang, J | 1 |
| Chang, CI; Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL | 1 |
| Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL | 1 |
| Bu, P; Hai, J; Hu, Y; Kong, B; Ma, X; Ti, Y; Yang, Y; Zhang, C; Zhao, Y; Zheng, X | 1 |
| Grujić-Milanović, J; Ivanov, M; Jaćević, V; Jovović, D; Karanović, D; Mihailović-Stanojević, N; Milanović, SD; Miloradović, Z; Vajić, UJ | 1 |
| Jojima, K; Node, K; Tanaka, A | 1 |
| Hsu, CN; Lin, YJ; Tain, YL | 1 |
| Carreón-Torres, E; Castrejón-Téllez, V; Díaz-Díaz, E; Guarner-Lans, V; Pérez-Torres, I; Rubio-Ruiz, ME; Villegas-Romero, M | 1 |
| Cebova, M; Dayar, E; Pechanova, O | 1 |
| Chan, JYH; Chang-Chien, GP; Hou, CY; Hsu, CN; Lee, CT; Lin, S; Tain, YL | 1 |
| Biffe, BG; Fabricio, V; Nonaka, KO; Oishi, JC; Rodrigues, GJ; Ruffoni, LD; Silva, KA | 1 |
| Hsu, CN; Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Yu, HR | 1 |
| Aquino, JCF; Cunha, AR; Gismondi, RO; Marques, BCAA; Neves, MF; Oigman, W; Trindade, M | 1 |
| Chen, HH; Cheng, PW; Lai, CC; Shin, CS; Sun, GC; Tseng, CJ; Yeh, TC | 1 |
| Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN | 1 |
| Bairwa, SC; Dyck, JRB; Kim, TT; Levasseur, J; Madsen, K; Parajuli, N; Schertzer, JD; Soltys, CM; Sung, MM; Wishart, DS | 1 |
| Ghorbanzadeh, H; Mashhadi, FD; Salari, R | 1 |
| Anand-Srivastava, MB; Li, Y; Sarkar, O | 1 |
| Chen, HE; Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tsai, CC; Yu, HR | 1 |
| Cicero, A; Fogacci, F; Fogacci, S | 1 |
| Dávalos, A; Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gil-Zamorano, J; Gonzálvez, M; Larrosa, M; Ruiz Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ | 1 |
| Beker, D; Chakrabarti, S; Davidge, ST; Dolinsky, VW; Dyck, JR; Levasseur, J; Lopaschuk, GD; Morton, JS; Nagendran, J; Oka, T; Pereira, TJ; Zordoky, BN | 1 |
| Carrizzo, A; Civitillo, F; Damato, A; Franco, E; Marino, M; Pompeo, F; Puca, A; Santini, L; Traficante, A; Trimarco, V; Vecchione, C | 1 |
| Anderson, HD; Behbahani, J; Fandrich, R; Kardami, E; Louis, XL; Movahed, A; Netticadan, T; Thandapilly, SJ; Yu, L; Zhang, S | 1 |
| Bós, Dda S; Dillenburg, DR; Duarte, AA; Ferreira, D; Irigoyen, MC; Moraes-Silva, IC; Mostarda, C; Rigatto, K | 1 |
| Bališ, P; Bernátová, I; Pecháňová, O; Púzserová, A; Sestáková, N; Slezák, P | 1 |
| Chen, BZ; Cheng, PW; Cheng, WH; Ho, WY; Hsiao, M; Lu, PJ; Lu, WH; Su, YT; Sun, GC; Tseng, CJ; Yeh, TC | 1 |
| Cao, X; Luo, T; Luo, X; Tang, Z | 1 |
| Akcali, KC; Ayaloglu-Butun, F; Demirel-Yilmaz, E; Han, S; Uludag, MO; Usanmaz, SE | 1 |
| Csiszar, A; Gautam, T; Giles, CB; Koller, A; Sonntag, WE; Springo, Z; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z; Wren, JD | 1 |
| Banday, AA; Javkhedkar, AA; Lokhandwala, MF; Quiroz, Y; Rodriguez-Iturbe, B; Vaziri, ND | 1 |
| Cicero, AF; Colletti, A | 1 |
| Badger, RS; Biesinger, S; Jalili, T; Michaels, HA; Qian, Y; Quadros, AS; Rabovsky, AB | 1 |
| Du, B; Li, YB; Meng, Y; Sun, GQ | 1 |
| Chen, J; Gao, M; Huang, X; Shen, X; Sun, J; Wang, L; Wang, Z; Xian, S; Yang, Z; Yuan, T | 1 |
| Denniss, SG; Ford, RJ; Jeffery, AJ; Rush, JW; Smith, CS | 1 |
| Bourque, SL; Care, AS; Davidge, ST; Dyck, JR; Gragasin, FS; Panahi, S; Sung, MM | 1 |
| Cha, L; Dai, Y; Li, J; Li, X; Liu, J; Mu, J; Shi, Y; Yan, S | 1 |
| Cao, YJ; Chen, XL; Fan, YP; Huang, XZ; Xue, HY; Yuan, L | 1 |
| Chen, HH; Cheng, PW; Hsiao, M; Lai, CC; Lee, HC; Lin, YT; Liu, CP; Lu, PJ; Sun, GC; Tseng, CJ; Yeh, TC | 1 |
| Cheserek, MJ; Karangwa, E; Le, G; Li, L; Shi, Y; Wu, G | 1 |
| Iranpour, D; Louis, XL; Movahed, A; Netticadan, T; Ostovar, A; Raj, P; Smoliga, JM; Thandapilly, SJ | 1 |
| Austin, C; Azzawi, M; Degens, H; Diaz, M; Vanhees, L | 1 |
| Acosta, C; Anderson, CM; Anderson, HD; Lee, DI | 1 |
| Galisteo, M; Morón, R; Rivera, L; Zarzuelo, A | 1 |
| Chan, AY; Des Rosiers, C; Dolinsky, VW; Dyck, JR; Light, PE; Robillard Frayne, I | 1 |
| Anderson, HD; Behbahani, J; Juric, D; Kopilas, MA; Louis, XL; Netticadan, T; Thandapilly, SJ; Wojciechowski, P; Yu, L | 1 |
| Wu, JM | 1 |
| Artyushkova, EB; Belous, AS; Brusnik, MS; Danilenko, LM; Kochkarov, VI; Korokin, MV; Korokina, LV; Malykhin, VA; Pashin, EN; Pokrovskaya, TG; Pokrovskii, MV; Zaloznykh, YI; Zhavbert, ES | 1 |
| Biala, A; Finckenberg, P; Louhelainen, M; Martonen, E; Merasto, S; Mervaala, E; Muller, DN; Shi, J; Siltanen, A; Tauriainen, E | 1 |
| Anderson, HD; Behbahani, J; Huang, Y; Kopilas, MA; Louis, XL; Netticadan, T; Shao, Z; Thandapilly, SJ; Wojciechowski, P | 1 |
| Berry, NM; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
| Brown, L; Chan, V; Fenning, A; Hoey, A; Iyer, A | 1 |
| Balasubramanian, P; Fink, GD; Garver, H; Haywood, JR; MohanKumar, PS; MohanKumar, SM; Northcott, C; Subramanian, M; Zhao, H | 1 |
| Banday, AA; Bhatt, SR; Lokhandwala, MF | 1 |
| Fortin, D; Garnier, A; Mateo, P; Piquereau, J; Rimbaud, S; Ruiz, M; Veksler, V; Ventura-Clapier, R | 1 |
| Das, DK; Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H | 1 |
| Gao, G; Gao, J; Hu, J; Jiang, X; Qin, X; Wang, X; Xiang, D; Xie, L | 1 |
| Amaral, TA; Franco, JG; Lima, NS; Lisboa, PC; Moura, EG; Oliveira, E; Passos, MC; Peixoto-Silva, N; Resende, AC | 1 |
| Cruzado, M; Miatello, R; Renna, N; Risler, N; Vázquez, M; Zumino, AP | 1 |
| Liu, ZP; Liu, ZQ; Song, Y; Zhang, XP | 1 |
| Das, DK; Juric, D; Netticadan, T; Wojciechowski, P | 1 |
| Ford, RJ; Levy, AS; Quadrilatero, J; Rush, JW | 1 |
| Lecour, S; Opie, LH | 1 |
| Artyushkova, EB; Danilenko, LM; Gumanova, NG; Kochkarov, VI; Korneev, MM; Metel'skaya, VA; Pashin, EN; Pokrovskaya, TG; Pokrovskii, MV | 1 |
| Hashimoto, T; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Sadoshima, J; Sunagawa, K | 1 |
| Ikeda, K; Kawai, Y; Mizutani, K; Yamori, Y | 1 |
| Ikeda, K; Mizutani, K; Nishikata, T; Yamori, Y | 1 |
8 review(s) available for resveratrol and Hypertension
| Article | Year |
|---|---|
Effects of resveratrol supplementation on nitric oxide-mediated vascular outcomes in hypertension: A systematic review.
Topics: Animals; Antioxidants; Dietary Supplements; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Plant-food-derived Bioactives in Managing Hypertension: From Current Findings to Upcoming Effective Pharmacotherapies.
Topics: Anthocyanins; Cardiovascular Diseases; Flavonoids; Humans; Hypertension; Lignans; Plant Extracts; Polyphenols; Resveratrol | 2023 |
Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
Topics: Animals; Antioxidants; Atherosclerosis; Biological Availability; Biological Products; Cardiovascular System; Curcumin; Drug Compounding; Heart Failure; Humans; Hypertension; Nanocapsules; Nitric Oxide; Nitric Oxide Synthase Type III; Polymers; Polyphenols; Quercetin; Reactive Oxygen Species; Resveratrol | 2020 |
The Effect of Resveratrol dose and Duration of Treatment on Blood Pressure in Patients with Cardiovascular Disorders: A Systematic Review.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Duration of Therapy; Humans; Hypertension; Resveratrol | 2020 |
Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.
Topics: Amino Acids; Beta vulgaris; Blood Pressure; Carotenoids; Clinical Trials as Topic; Dietary Supplements; Fatty Acids, Unsaturated; Flavonoids; Fruit and Vegetable Juices; Garlic; Humans; Hypertension; Lycopene; Magnesium; Melatonin; Meta-Analysis as Topic; Minerals; Peptides; Plant Extracts; Potassium; Probiotics; Proteins; Resveratrol; Stilbenes; Ubiquinone; Vitamins | 2015 |
The effects of resveratrol on aging vessels.
Topics: Aging; Animals; Antioxidants; Arteriosclerosis; Autophagy; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Oxidative Stress; Resveratrol; Stilbenes | 2016 |
The red wine hypothesis: from concepts to protective signalling molecules.
Topics: Alcohol Drinking; Animals; Arteriosclerosis; Coronary Disease; Female; Flavonoids; Humans; Hypertension; Male; Mice; Phenols; Platelet Aggregation; Platelet Aggregation Inhibitors; Polyphenols; Rats; Resveratrol; Risk Factors; Stilbenes; Wine | 2007 |
8 trial(s) available for resveratrol and Hypertension
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial.
Topics: Ankle Brachial Index; Dietary Supplements; Fibrosis; Humans; Hypertension; Pulse Wave Analysis; Resveratrol; Ventricular Function, Left; Ventricular Remodeling | 2023 |
Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction.
Topics: Antioxidants; Aorta; Blood Pressure; Brachial Artery; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Resveratrol; Sex Factors; Stilbenes; Vasodilation | 2018 |
One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Cytokines; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Humans; Hypertension; Inflammation; Leukocytes, Mononuclear; Male; MicroRNAs; Middle Aged; Models, Molecular; Plant Extracts; Resveratrol; Stilbenes; Transcriptome; Vitis | 2013 |
A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.
Topics: Adult; Antihypertensive Agents; Antioxidants; Blood Pressure; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Magnoliopsida; Male; Metabolic Syndrome; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Phytochemicals; Phytotherapy; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2016 |
The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial.
Topics: Clinical Protocols; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Outcome Assessment, Health Care; Resveratrol; Sample Size; Stilbenes | 2016 |
Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Overweight; Placebos; Resveratrol; Risk Factors; Stilbenes; Vasodilation | 2011 |
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
Topics: Aged; Diabetes Mellitus; Drug Compounding; Endothelium, Vascular; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents | 2011 |
61 other study(ies) available for resveratrol and Hypertension
| Article | Year |
|---|---|
Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heart; Hypertension; Male; Mitophagy; NLR Family, Pyrin Domain-Containing 3 Protein; Physical Conditioning, Animal; Proteins; Rats, Wistar; Resveratrol; Stress, Physiological | 2022 |
Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury.
Topics: Animals; Biomarkers; Chemical and Drug Induced Liver Injury, Chronic; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Cirrhosis; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Resveratrol; Thioacetamide; Tumor Necrosis Factor-alpha | 2022 |
Resveratrol inhibits cerebral aneurysms in mice via downregulating the NF-κB pathway.
Topics: Animals; Hypertension; Intracranial Aneurysm; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; NF-kappa B; Resveratrol; Sodium Chloride | 2022 |
Resveratrol in the Hypothalamic Paraventricular Nucleus Attenuates Hypertension by Regulation of ROS and Neurotransmitters.
Topics: Animals; Copper; Glutamate Decarboxylase; Hypertension; Male; NADPH Oxidases; Neurotransmitter Agents; NF-kappa B; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Superoxide Dismutase-1; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Zinc | 2022 |
Resveratrol alleviates preeclampsia-like symptoms in rats through a mechanism involving the miR-363-3p/PEDF/VEGF axis.
Topics: Animals; Female; Humans; Hypertension; MicroRNAs; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Resveratrol; Trophoblasts; Vascular Endothelial Growth Factor A | 2023 |
A network pharmacology study on mechanism of resveratrol in treating preeclampsia
Topics: Child; ErbB Receptors; Female; Humans; Hypertension; Hypoxia-Inducible Factor 1; Infant; Interleukin-6; Molecular Docking Simulation; Network Pharmacology; Pre-Eclampsia; Pregnancy; Resveratrol | 2022 |
Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model.
Topics: Adenine; Animals; Butyrates; Dietary Supplements; Hypertension; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Resveratrol | 2023 |
Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model.
Topics: Animals; Butyrates; Dietary Supplements; Diethylhexyl Phthalate; Esters; Fatty Acids, Volatile; Female; Hypertension; Maternal Exposure; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol | 2023 |
Resveratrol improved kidney function and structure in malignantly hypertensive rats by restoration of antioxidant capacity and nitric oxide bioavailability.
Topics: Animals; Antioxidants; Biological Availability; Blood Pressure; Hypertension; Hypertension, Malignant; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Resveratrol | 2022 |
Resveratrol supplementation: a therapeutic potential for cardiac remodeling in hypertensive heart disease.
Topics: Dietary Supplements; Heart Diseases; Humans; Hypertension; Resveratrol; Ventricular Remodeling | 2023 |
Maternal Exposure to Bisphenol A Combined with High-Fat Diet-Induced Programmed Hypertension in Adult Male Rat Offspring: Effects of Resveratrol.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Female; Hypertension; Immunohistochemistry; Male; Maternal Exposure; Nitric Oxide; Oxidative Stress; Phenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol | 2019 |
Effect of a Resveratrol/Quercetin Mixture on the Reversion of Hypertension Induced by a Short-Term Exposure to High Sucrose Levels Near Weaning and a Long-Term Exposure That Leads to Metabolic Syndrome in Rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Biomarkers; Disease Models, Animal; Drug Combinations; Gene Expression Regulation; Hypertension; Male; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Quercetin; Rats; Resveratrol; Sirtuin 1; Sucrose; Superoxide Dismutase; Weaning | 2020 |
Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide.
Topics: Animals; Antioxidants; Arginine; Female; Gastrointestinal Microbiome; Hypertension; Methylamines; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Rats; Renin-Angiotensin System; Resveratrol | 2021 |
Resveratrol Treatment Normalizes the Endothelial Function and Blood Pressure in Ovariectomized Rats.
Topics: Animals; Antioxidants; Blood Pressure; Endothelium, Vascular; Estrogens; Female; Hypertension; Nitrates; Nitric Oxide; Nitrites; Ovariectomy; Rats, Wistar; Reference Values; Reproducibility of Results; Resveratrol; Stilbenes; Time Factors; Treatment Outcome | 2017 |
Resveratrol prevents the combined maternal plus postweaning high-fat-diets-induced hypertension in male offspring.
Topics: Animals; Arginine; Blood Pressure; Diet, High-Fat; Female; Hypertension; Male; Maternal Nutritional Physiological Phenomena; Oxidative Stress; Pregnancy; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Stilbenes; Weaning | 2017 |
Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Blood Pressure; Blood Pressure Determination; Central Nervous System; Down-Regulation; Hypertension; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; Nitric Oxide Synthase Type I; Oxidative Stress; rac1 GTP-Binding Protein; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; Signal Transduction; Superoxide Dismutase | 2018 |
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling | 2018 |
Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Colon; Cytokines; Diet, High-Fat; Dietary Sucrose; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Hyperglycemia; Hypertension; Inflammation; Magnetic Resonance Spectroscopy; Metabolic Syndrome; Mice; Obesity; Resveratrol | 2018 |
Resveratrol prevents the development of high blood pressure in spontaneously hypertensive rats through the inhibition of enhanced expression of Giα proteins
Topics: Animals; CSK Tyrosine-Protein Kinase; Enzyme Activation; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; Hypertension; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Resveratrol; Signal Transduction; Superoxides | 2019 |
Resveratrol prevents combined prenatal N
Topics: Animals; Diet, High-Fat; Discriminant Analysis; Enzyme Inhibitors; Female; Gastrointestinal Microbiome; Hypertension; Maternal Exposure; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nutrients; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Resveratrol | 2019 |
Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient?
Topics: Blood Pressure; Dietary Supplements; Humans; Hypertension; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol | 2019 |
Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
Topics: Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Humans; Hypertension; Mice; Rats; Resveratrol; Stilbenes | 2013 |
Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.
Topics: Acetylcholine; Biopterins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Resveratrol; Stilbenes; Superoxide Dismutase; Vasodilation | 2013 |
Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hydralazine; Hypertension; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2013 |
Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats.
Topics: Animals; Autonomic Nervous System; Beverages; Cardiovascular System; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Hypertension; Male; NG-Nitroarginine Methyl Ester; Oxidation-Reduction; Rats; Rats, Wistar; Resveratrol; Stilbenes; Vasodilator Agents; Vitis | 2013 |
Short-term administration of alibernet red wine extract failed to affect blood pressure and to improve endothelial function in young normotensive and spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Male; Peripheral Arterial Disease; Plant Extracts; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes; Treatment Failure; Treatment Outcome; Vascular Resistance; Wine | 2013 |
Resveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanism.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Blood Pressure; Cerebellum; Fructose; Hypertension; Male; NADPH Oxidases; Nitric Oxide Synthase Type I; Nitrogen Oxides; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; Solitary Nucleus; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1 | 2014 |
Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Topics: Adenylate Kinase; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Resveratrol; rho-Associated Kinases; rhoA GTP-Binding Protein; Stilbenes | 2014 |
Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension.
Topics: Animals; Antioxidants; Arginine; Biomarkers; Blood Pressure; Blood Vessels; Desoxycorticosterone Acetate; Endothelium, Vascular; Fluorescent Antibody Technique; Histones; Hydrogen Sulfide; Hypertension; Lysine; Male; Methylation; Nitrites; Rats, Wistar; Renal Artery; Resveratrol; Stilbenes; Systole; Vasodilation | 2015 |
Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection.
Topics: Aging; Animals; Blood Pressure; Brain; Disease Models, Animal; Hypertension; Intracranial Hemorrhages; Male; Mice, Inbred C57BL; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2015 |
Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Drinking; Eating; Hypertension; Inflammation; Kidney; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2015 |
Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice.
Topics: AMP-Activated Protein Kinases; Animals; Anticarcinogenic Agents; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Enzyme Activation; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Resveratrol; Stilbenes; Vasoconstriction; Vasodilator Agents | 2015 |
Resveratrol Ameliorates Pressure Overload-induced Cardiac Dysfunction and Attenuates Autophagy in Rats.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Blotting, Western; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Heart Function Tests; Hypertension; Male; Myocardium; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Chronic in vivo or acute in vitro resveratrol attenuates endothelium-dependent cyclooxygenase-mediated contractile signaling in hypertensive rat carotid artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; AMP-Activated Protein Kinases; Animals; Carotid Artery, Common; Endothelium, Vascular; Hypertension; Male; Muscle Contraction; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Thromboxane; Resveratrol; Signal Transduction; Stilbenes; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2016 |
Perinatal Resveratrol Supplementation to Spontaneously Hypertensive Rat Dams Mitigates the Development of Hypertension in Adult Offspring.
Topics: Adult; Adult Children; Animals; Animals, Newborn; Dietary Supplements; Disease Models, Animal; Female; Humans; Hypertension; Male; Perinatal Care; Pregnancy; Pregnancy, Animal; Random Allocation; Rats; Rats, Inbred SHR; Reference Values; Resveratrol; Stilbenes | 2016 |
Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Blood Pressure; Calcium; Disease Models, Animal; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes; Vasodilation | 2016 |
Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.
Topics: Acute Kidney Injury; Animals; beta 2-Microglobulin; Blood Pressure; Collagen Type I; Disease Models, Animal; Fibronectins; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Inflammation; Kidney; Plasminogen Activator Inhibitor 1; Rats; Resveratrol; Stilbenes; Transforming Growth Factor beta1 | 2016 |
Resveratrol Inhibition of Rac1-Derived Reactive Oxygen Species by AMPK Decreases Blood Pressure in a Fructose-Induced Rat Model of Hypertension.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Blood Pressure; Disease Models, Animal; Enzyme Activators; Fructose; Hypertension; rac1 GTP-Binding Protein; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Cardioprotective effects of lipoic acid, quercetin and resveratrol on oxidative stress related to thyroid hormone alterations in long-term obesity.
Topics: Animals; Anti-Obesity Agents; Antihypertensive Agents; Antioxidants; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Diet, High-Fat; Female; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypothyroidism; Mice, Inbred C57BL; Obesity; Oxidative Stress; Quercetin; Random Allocation; Resveratrol; Stilbenes; Thioctic Acid; Thyroid Hormones; Weight Gain | 2016 |
Peripheral and Cerebral Resistance Arteries in the Spontaneously Hypertensive Heart Failure Rat: Effects of Stilbenoid Polyphenols.
Topics: Animals; Blood Pressure; Disease Models, Animal; Hypertension; Male; Mesenteric Arteries; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vascular Resistance | 2017 |
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
Topics: Adipose Tissue; Animals; Blood Pressure; Disease Models, Animal; Drug Administration Schedule; Humans; Hypertension; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Zucker; Resveratrol; Stilbenes | 2009 |
Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Topics: Aldehydes; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Myocytes, Cardiac; Oxidative Stress; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.
Topics: Aging; Animals; Antioxidants; Blood Pressure; Cardiomegaly; Echocardiography; Heart Function Tests; Hypertension; Lipid Peroxidation; Male; Myocardial Contraction; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2010 |
Resveratrol alleviates some cardiac dysfunction indexes in an SHR model of essential hypertension.
Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Contraction; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2010 |
Comparative study of potential endothelioprotectors and impaza in modeled nitric oxide deficiency.
Topics: Animals; Antibodies; Antihypertensive Agents; Antioxidants; Endothelium, Vascular; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2009 |
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Genes; Heart; Humans; Hypertension; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes | 2010 |
Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat.
Topics: Aging; Animals; Blood Pressure; Compliance; Hypertension; Male; Mesenteric Arteries; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes; Vascular Resistance | 2010 |
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Desoxycorticosterone; Fibrosis; Heart; Heart Ventricles; Humans; Hypertension; Male; Mineralocorticoids; Rats; Rats, Wistar; Resveratrol; Sodium Chloride, Dietary; Stilbenes; Ventricular Remodeling | 2011 |
Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Estradiol; Estrogens; Heart Rate; Hypertension; Male; Medulla Oblongata; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxides | 2011 |
Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Drinking; Eating; Endothelium, Vascular; Heart; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes; Tyrosine | 2011 |
Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure.
Topics: Animals; Body Weight; Disease Models, Animal; Endothelium, Vascular; Energy Metabolism; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mitochondria; Rats; Rats, Inbred Dahl; Resveratrol; Signal Transduction; Stilbenes; Survival Analysis | 2011 |
Effects of trimethoxystilbene on proliferation and apoptosis of pulmonary artery smooth muscle cells.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Flow Cytometry; Humans; Hypertension; Inflammation; Male; Myocytes, Smooth Muscle; Pulmonary Artery; Rats; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2012 |
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
Topics: Animals; Antioxidants; Blood Glucose; Dyslipidemias; Fatty Liver; Female; Glutathione Peroxidase; Hyperphagia; Hypertension; Insulin Resistance; Liver; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weaning | 2013 |
Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats.
Topics: Administration, Oral; Animal Feed; Animals; Antioxidants; Arteriosclerosis; Biomarkers; Blood Pressure; Follow-Up Studies; Fructose; Heart Ventricles; Hypertension; Insulin Resistance; Lipid Peroxidation; Male; Mesenteric Arteries; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Spectrophotometry; Stilbenes; Sweetening Agents; Thiobarbituric Acid Reactive Substances; Time Factors | 2005 |
[Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension; Male; Myocardium; Nephrectomy; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol.
Topics: Animals; Aorta; Dose-Response Relationship, Drug; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Endothelium; Hydrogen Peroxide; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents | 2007 |
Effect of antioxidants pQ510 and resveratrol on regulatory function of the endothelium in rats with modeled arterial hypertension.
Topics: Animals; Antioxidants; Ascorbic Acid; Endothelium, Vascular; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2007 |
SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Hypertension; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Niacinamide; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Resveratrol; RNA, Messenger; Sirtuin 1; Sirtuins; Sp1 Transcription Factor; Stilbenes; Time Factors; Transcription, Genetic; Transfection | 2008 |
Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Bone Density; Disease Models, Animal; Female; Femur; Hypertension; Osteoporosis; Ovariectomy; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2000 |
Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Topics: Animals; Base Sequence; Cells, Cultured; DNA Damage; DNA Primers; Estrogens, Non-Steroidal; Genistein; Glutathione; Glutathione Peroxidase; Glycation End Products, Advanced; Hypertension; Isoflavones; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Phytoestrogens; Plant Preparations; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Stilbenes; Stroke | 2000 |